ArticleFrontiers in pharmacology2025
Computational and experimental identification of putative αTAT1 modulators: implications for nervous system function.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The project's primary objective is to understand how enzymes responsible for post-translational modifications (PTMs) of microtubule elements influence ion channels in excitatory peripheral nervous system (PNS) cells, and to subsequently identify potential pharmacological agents that can act upon these molecular targets. Having identified HDAC6 and αTAT1 as the most relevant proteins for further study, we focused on αTAT1. αTAT1 is the sole mammalian enzyme known to acetylate microtubules, a process associated with regulating their dynamics and protecting long-lived microtubules from mechanical stress. Additionally, αTAT1 plays a role in nuclear processes such as DNA replication, cell migration, and axonal transport. Given the importance of αTAT1 in cytoskeletal homeostasis and the lack of known effectors, our research focused on this enzyme. Methods: We designed a corresponding pharmacophore model hypothesis of ligand-dependent inhibition for αTAT1 and performed search for potential αTAT1 modulators using molecular interaction analysis and existing crystal structures. Confocal microscopy was used to assess cytoskeletal changes in a neural stem cell line following experimental treatment. Results: The activity of identified hits was confirmed via confocal microscopy. This allowed for further tuning of our screening models and generation of novel subsets of compounds.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.